Table 1.

Characteristics of adults with and without diabetes in the United States from 2009 to 2014

CharacteristicNo Diabetes Mellitus, n=13,396Diabetes Mellitus, n=2279
NWeighted Proportion (95% CI) or Mean (95% CI)NWeighted Proportion (95% CI) or Mean (95% CI)
Proportion of United States population89.2 (88.6 to 89.9)10.8 (10.1 to 11.4)
Demographic variables
 Age, yr46 (45 to 47)59 (58 to 60)
 Women, %695152 (51 to 53)109348 (45 to 51)
 Race/ethnicity, %
  White, non-Hispanic604468 (64 to 73)78060 (55 to 64)
  Black, non-Hispanic260110 (8 to 12)59915 (12 to 19)
  Mexican American18398 (6 to 11)39810 (7 to 14)
Medical history
 History of hypertension, %403628 (26 to 29)153966 (64 to 69)
 Duration of hypertension, yr10.2 (9.7 to 10.6)13.7 (12.8 to 14.5)
 Duration of diabetes, yra0 (0 to 0)5 (0 to 13)
Medication use
 Antihypertensive medications, %328823 (21 to 24)162670 (68 to 73)
 RAS inhibitors, %198314 (13 to 15)129356 (53 to 59)
  ACE inhibitors12699 (8 to 10)85937 (34 to 39)
  Angiotensin receptor blockers6614.4 (3.7 to 5.1)44020 (17 to 22)
BP, mm Hg
 Systolic BP120.3 (119.7 to 120.8)129.7 (128.5 to 130.9)
 Diastolic BP70.4 (69.7 to 71.0)68.9 (67.9 to 69.9)
  • Diabetes is defined to be use of antidiabetic medications or a hemoglobin A1c ≥6.5%. Cell contents are raw numbers of participants or weighted proportions or means (95% CI) of United States adults with or without diabetes mellitus with the indicated characteristic, as appropriate, except for row 3, which presents weighted proportions (95% CI) of all United States adults with and without diabetes mellitus. 95% CI, 95% confidence interval; RAS, renin-angiotensin system; ACE, angiotensin-converting enzyme.

  • a Median (interquartile range) duration of diabetes for United States adults with or without diabetes mellitus.